Anti-hepatitis C virus therapy in chronic kidney disease patients improves long-term renal and patient survivals

BACKGROUND: Hepatitis C virus (HCV) infection is a documented risk factor for chronic kidney disease (CKD) and progression to end-stage renal disease (ESRD). However, to date there are no reports on the long-term hard endpoints (ESRD and death) of anti-HCV therapy [interferon-based therapy (IBT) or...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yi-Chun, Li, Chung-Yi, Tsai, Shiang-Jiun, Chen, Yen-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Retrospective Cohort Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580345/
https://www.ncbi.nlm.nih.gov/pubmed/31236391
http://dx.doi.org/10.12998/wjcc.v7.i11.1270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580345/
https://www.ncbi.nlm.nih.gov/pubmed/31236391
http://dx.doi.org/10.12998/wjcc.v7.i11.1270

Ejemplares similares